Anticancer effect of myristicin on hepatic carcinoma and related molecular mechanism

References

• Alzahrani AS. 2019. PI3K/Akt/mTOR inhibitors in cancer: at the bench and bedside. Semin Cancer Biol. 59:125–132.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Chedid MF, Kruel CRP, Pinto MA, Grezzana-Filho TJM, Leipnitz I, Kruel CDP, Scaffaro LA, Chedid AD. 2017. Hepatocellular carcinoma: diagnosis and operative management. Arq Bras Cir Dig. 30(4):272–278.
   PubMed Web of Science ®Google Scholar
• Costa RLB, Han HS, Gradishar WJ. 2018. Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review. Breast Cancer Res Treat. 169(3):397–406.
   PubMed Web of Science ®Google Scholar
• Ediriweera MK, Tennekoon KH, Samarakoon SR. 2019. Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: biological and therapeutic significance. Semin Cancer Biol. 59:147–160.
   PubMed Web of Science ®Google Scholar
• El Jabbour T, Lagana SM, Lee H. 2019. Update on hepatocellular carcinoma: pathologists' review. World J Gastroenterol. 25(14):1653–1665.
   PubMed Web of Science ®Google Scholar
• Farazi PA, DePinho RA. 2006. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 6(9):674–687.
   PubMed Web of Science ®Google Scholar
• Hallström H, Thuvander A. 1997. Toxicological evaluation of myristicin. Nat Toxins. 5(5):186–192.
   PubMedGoogle Scholar
• Hartke J, Johnson M, Ghabril M. 2017. The diagnosis and treatment of hepatocellular carcinoma. Semin Diagn Pathol. 34(2):153–159.
   PubMed Web of Science ®Google Scholar
• Hua H, Zhu Y, Song YH. 2018. Ruscogenin suppressed the hepatocellular carcinoma metastasis via PI3K/Akt/mTOR signaling pathway. Biomed Pharmacother. 101:115–122.
   PubMed Web of Science ®Google Scholar
• Jana S, Shekhawat GS. 2010. Anethum graveolens: an Indian traditional medicinal herb and spice. Pharmacogn Rev. 4(8):179–184.
   PubMedGoogle Scholar
• Jeong YJ, Choi Y, Shin JM, Cho HJ, Kang JH, Park KK, Choe JY, Bae YS, Han SM, Kim CH, et al. 2014. Melittin suppresses EGF-induced cell motility and invasion by inhibiting PI3K/Akt/mTOR signaling pathway in breast cancer cells. Food Chem Toxicol. 68:218–225.
   PubMed Web of Science ®Google Scholar
• Kudo M. 2011. mTOR inhibitor for the treatment of hepatocellular carcinoma. Dig Dis. 29(3):310–315.
   PubMed Web of Science ®Google Scholar
• Lamouille S, Xu J, Derynck R. 2014. Molecular mechanisms of epithelial–mesenchymal transition. Nat Rev Mol Cell Biol. 15(3):178–196.
   PubMed Web of Science ®Google Scholar
• Lee BK, Kim JH, Jung JW, Choi JW, Han ES, Lee SH, Ko KH, Ryu JH. 2005. Myristicin-induced neurotoxicity in human neuroblastoma SK-N-SH cells. Toxicol Lett. 157(1):49–56.
   PubMed Web of Science ®Google Scholar
• Lee JY, Park W. 2011. Anti-inflammatory effect of myristicin on RAW 264.7 macrophages stimulated with polyinosinic–polycytidylic acid. Molecules. 16(8):7132–7142.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Margarit C, Escartín A, Castells L, Vargas V, Allende E, Bilbao I. 2005. Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation. Liver Transpl. 11(10):1242–1251.
   PubMed Web of Science ®Google Scholar
• Martins C, Doran C, Laires A, Rueff J, Rodrigues AS. 2011. Genotoxic and apoptotic activities of the food flavourings myristicin and eugenol in AA8 and XRCC1 deficient EM9 cells. Food Chem Toxicol. 49(2):385–392.
   PubMed Web of Science ®Google Scholar
• Muchtaridi A, Subarnas A, Apriyantono R. 2010. Identification of compounds in the essential oil of nutmeg seeds (Myristica fragrans Houtt.) that inhibit locomotor activity in mice. Int J Mol Sci. 11:4771–4781.
   PubMed Web of Science ®Google Scholar
• Ramadan F, Fahs A, Ghayad SE, Saab R. 2020. Signaling pathways in rhabdomyosarcoma invasion and metastasis. Cancer Metastasis Rev. 39(1):287–301.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. 2019. Cancer statistics, 2019. CA Cancer J Clin. 69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Sivathanu S, Sampath S, David HS, Rajavelu KK. 2014. Myristicin and phenytoin toxicity in an infant. BMJ Case Rep. 2014:bcr2013203000.
   PubMedGoogle Scholar
• Song Q, Zhang H, He J, Kong H, Tao R, Huang Y, Yu H, Zhang Z, Huang Z, Wei L, et al. 2020. Long non-coding RNA LINC00473 acts as a microRNA-29a-3p sponge to promote hepatocellular carcinoma development by activating Robo1-dependent PI3K/AKT/mTOR signaling pathway. Ther Adv Med Oncol. 12:1758835920937890.
   Web of Science ®Google Scholar
• Stefano VD, Pitonzo R, Schillaci D. 2011. Antimicrobial and antiproliferative activity of Athamanta sicula L. (Apiaceae). Pharmacogn Mag. 7(25):31–34.
   PubMed Web of Science ®Google Scholar
• Stein U, Greyer H, Hentschel H. 2001. Nutmeg (myristicin) poisoning-report on a fatal case and a series of cases recorded by a poison information centre. Forensic Sci Int. 118(1):87–90.
   PubMed Web of Science ®Google Scholar
• Sun L, Wang L, Chen T, Yao B, Wang Y, Li Q, Yang W, Liu Z. 2019. microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC. J Cell Mol Med. 23(12):8292–8304.
   PubMed Web of Science ®Google Scholar
• Wei A, Shibamoto T. 2007. Antioxidant activities and volatile constituents of various essential oils. J Agric Food Chem. 55(5):1737–1742.
   PubMed Web of Science ®Google Scholar
• Wu YJ, Neoh CA, Tsao CY, Su JH, Li HH. 2015. Sinulariolide suppresses human hepatocellular carcinoma cell migration and invasion by inhibiting matrix metalloproteinase-2/-9 through MAPKs and PI3K/Akt signaling pathways. Int J Mol Sci. 16(7):16469–16482.
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen L, Gu J, Zhang H, Yuan J, Lian Q, Lv G, Wang S, Wu Y, Yang YT, et al. 2017. Recurrently deregulated lncRNAs in hepatocellular carcinoma. Nat Commun. 8:14421.
   PubMed Web of Science ®Google Scholar
• Ye L, Mayerle J, Ziesch A, Reiter FP, Gerbes AL, De Toni EN. 2019. The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma. Cell Death Discov. 5:86–97.
   PubMed Web of Science ®Google Scholar
• Ye X, Brabletz T, Kang Y, Longmore GD, Nieto MA, Stanger BZ, Yang J, Weinberg RA. 2017. Upholding a role for EMT in breast cancer metastasis. Nature. 547(7661):E1–E3.
   PubMed Web of Science ®Google Scholar
• Zheng GQ, Kenney PM, Zhang J, Lam LKT. 1992. Inhibition of benzo[a]pyrene-induced tumorigenesis by myristicin, a volatile aroma constituent of parsley leaf oil. Carcinogenesis. 13(10):1921–1923.
   PubMed Web of Science ®Google Scholar